Verrica Pharmaceuticals Inc. (VRCA) financial statements (2020 and earlier)

Company profile

Business Address 10 NORTH HIGH STREET
WEST CHESTER, PA 19380
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments910
Cash and cash equivalents910
Other undisclosed current assets5681
Total current assets:6591
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment20
Deposits noncurrent assets10
Total noncurrent assets:31
TOTAL ASSETS:6892
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities32
Accounts payable11
Accrued liabilities22
Debt0 
Due to related parties 0
Total current liabilities:32
Noncurrent Liabilities
Long-term debt and lease obligation0 
Operating lease, liability0
Total noncurrent liabilities:0 
Total liabilities:32
Stockholders' equity
Stockholders' equity attributable to parent6589
Common stock00
Additional paid in capital127123
Accumulated other comprehensive income (loss)0(0)
Accumulated deficit(61)(33)
Stockholders' equity note, subscriptions receivable(0) 
Total stockholders' equity:6589
TOTAL LIABILITIES AND EQUITY:6892

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Operating expenses(30)(22)
Other operating expense, net
(Other Expenses)
(0)(0)
Other undisclosed operating income00
Operating loss:(30)(22)
Nonoperating income21
Investment income, nonoperating21
Net loss available to common stockholders, diluted:(28)(21)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(28)(21)
Comprehensive loss:(28)(21)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)
Comprehensive loss, net of tax, attributable to parent:(28)(21)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: